Share This

Related Topics News -

     
 Title only   |   Print 
     
《大行》大摩降信達生物目標價至66.5元 康諾亞-B下調至50元

2024-05-08T  
宜明昂科核心產品替達派西普III期臨床試驗方案獲批

2024-04-18T  
《公司業績》宜明昂科全年虧損收窄至3.79億人民幣

2024-03-26T  
宜明昂科不悉股價波動原因 基石投資者禁售期屆滿

2024-03-07T  
《大行報告》中金:國指及科指檢討結果料對聯通及同程影響正面 22隻股份或符納入港股通

2024-02-20T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.